Author Micah Kindred discusses Nintendo’s new patent and how software is under protected in the current intellectual property landscape.
Nintendogs, Patents, and How the System is Lacking
Deepfakes: The Effect on Women and Potential Protections
Author Micah Kindred discusses deepfakes, the effect this technology has had on individuals, especially women, and potential protections.
Dude, Where’s My (Self-Driving) Car? The Legal Implications of the Self-Repossessing Automobile Under Article 9 of the U.C.C.
In this article, James Hardman explores some of the legal implications of proposed new technology allowing banks to remotely order cars subject to delinquent loans to repossess themselves.
Artificial Intelligence: Power Imbalanced
In a wide-encompassing article, Associate Member Jacob Metzger discusses the rapid expansion of artificial intelligence in copyright law, the unauthorized practice of law, personal autonomy, and legal access.
Too Much of a Good Thing: How Genericide Sends Trademarks to the Graveyard
Jacob Metzger discusses the effect of genericide on trademarks and argues for more aggressive marketing campaigns in preventing the legal phenomenon, otherwise, brand owners may find themselves wiping their tears with a kleenex, as opposed to a Kleenex® brand tissue.
Adidas “Does Not Own Stripes”
Caroline Hardig discusses the trademark infringement lawsuit over Adidas’s three-stripe design. She explains the outcome of the lawsuit and the future implications this lawsuit may have on brands who use a striped design.
Red Bottom Heels: The Trademark Dispute
In this article, Author Micah Kindred discusses Louboutin’s quest for a trademark in Japan.
NFTs and Intellectual Property Rights: What We Know and What Is Coming
Author Micah Kindred discusses NFT intellectual property rights in part two of an article series on the current NFT landscape.
Patents and AI-Generated Works: Should AI Be Designated as Inventors?
In her most recent article for the University of Cincinnati Law Review Blog, Associate Member Emmaline Fisher discusses the issue of inventorship for AI-generated works.
Patent Evergreening and the Response by the USPTO and FDA
In her most recent blog post, Associate Member Emmaline Fisher discusses patent evergreening, its effects on prescription drug prices, and the USPTO’s and the FDA’s response to President Biden’s Executive Order that this issue be addressed and fixed.